Pliant Therapeutics, Inc.PLRXNASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P68
Within normal range
vs 2Y Ago
0.5x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 15.62% |
| Q3 2025 | 48.08% |
| Q2 2025 | 16.91% |
| Q1 2025 | -2.52% |
| Q4 2024 | -47.68% |
| Q3 2024 | 28.75% |
| Q2 2024 | -49.64% |
| Q1 2024 | -20.59% |
| Q4 2023 | 30.70% |
| Q3 2023 | -46.31% |
| Q2 2023 | 18.22% |
| Q1 2023 | 3.08% |
| Q4 2022 | -68.88% |
| Q3 2022 | 24.18% |
| Q2 2022 | -19.02% |
| Q1 2022 | -3.19% |
| Q4 2021 | 11.75% |
| Q3 2021 | -16.01% |
| Q2 2021 | -41.99% |
| Q1 2021 | 17.11% |
| Q4 2020 | -4.39% |
| Q3 2020 | -303.19% |
| Q2 2020 | 160.88% |
| Q1 2020 | -134.74% |
| Q4 2019 | 347.00% |
| Q3 2019 | -8.02% |
| Q2 2019 | -26.96% |
| Q1 2019 | 0.00% |
| Q1 2018 | 0.00% |